Author’s Note: This story first published more than a decade ago in Outdoor Life magazine. I’m a firm believer that some of our hunting memories can only be truly appreciated in time. It’s not that we ...

Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...

A few short years ago, major crossbow brands like Ravin and TenPoint were in a race to break the 500-feet-per-second mark, and both were successful. I tested and hunted extensively with such ...

I have killed five bears above the black-bear class with a bow in the last six years and tackled two others that proved too much to handle that way and had to be stopped with a rifle. From those seven ...